Publications by authors named "Nathan Poterszman"

Claim this Profile
N
Neuroendocrine peritoneal disease and [Lu]DOTATATE peptide receptor radionuclide therapy: a therapeutic challenge with potential clinical complications.
Nathan Poterszman, Philippe Baltzinger, Darejan Mamulashvili Bessac, Floriane Pham Van, Bernard Goichot

Eur J Nucl Med Mol Imaging· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Visceral metastases, platelet dynamics, and PSA decline: from biomarkers to better outcomes in [Lu]Lu‑PSMA‑617 therapy in metastatic castration-resistant prostate cancer.
Nathan Poterszman, Cécile Hammer-Lefevre, Clémence Porot, Julien Salvadori, Philippe Barthélémy

Theranostics· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Organ-specific response to [Lu]DOTATATE peptide receptor radionuclide therapy (PRRT) assessed by sequential [Ga]DOTATOC PET/CT in patients with metastatic small intestine neuroendocrine tumors.
Darejan Mamulashvili Bessac, Philippe Baltzinger, Nathan Poterszman, Floriane Pham Van, Cedric Collen

Endocrine· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Hangover Under 177 Lu-PSMA-617 Therapy : A Red Flag for Brain 68 Ga-PSMA-11 PET/MRI?
Nathan Poterszman, Laura Somme, Caroline Bund, Emilie Hutt, François Somme

Clin Nucl Med· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A bicentric retrospective study of the correlation of EAU BCR risk groups with F-PSMA-1007 PET/CT detection in prostate cancer biochemical recurrence.
Nathan Poterszman, Charles Merlin, Charles Margail, Eric Ouvrard, Alessio Imperiale

Sci Rep· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nuclear medicine imaging for bone metastases assessment: what else besides bone scintigraphy in the era of personalized medicine?
Eric Ouvrard, Ashjan Kaseb, Nathan Poterszman, Clémence Porot, Francois Somme

Front Med (Lausanne)· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular imaging phenotyping of germline fumarate hydratase (FH) pathogenic variant-positive metastatic pheochromocytoma.
Alessio Imperiale, Miriam Pepponi, Nathan Poterszman, Abhishek Jha, Cedric Collen

Eur J Nucl Med Mol Imaging· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis